Dr Olayemi Olupitan is the Project Director of the Global Fund (GF) Grant Cycle 7 Tuberculosis/HIV project of the Institute of Human Virology Nigeria (IHVN). In this interview, she spoke on ways to ...

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

While a U.S. federal judge ordered the Trump administration to reverse the funding freeze, the effect isn’t immediate.

AstraZeneca (AZN) has reported positive results from an analysis of its NIAGARA Phase 3 study of Imfinzi in the treatment of ...

Dr Shreya Dubey - Consultant - Neonatology & Paediatrics, CK Birla Hospital Gurgaon revealed that children are highly ...

As part of the '100 Days TB Eradication Campaign,' a special programme was organised on Friday in Gandhinagar under the ch ...

The rise in multidrug-resistant tuberculosis MDR-TB among children is raising global health concerns Learn about its causes alarming trends and the urgent need for action ...

Introduction Globally, tuberculosis (TB) remains one of the leading infectious causes of death, with 1.3 million deaths.

A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...

Mumbai: Only 150 to 200 doses of the new TB treatment for drug-resistant patients have been supplied to Maharashtra, most of which will be allocated t.

The Trump administration's freeze on foreign aid delivered through the US Agency for International Development (USAID), and ...

In part 2 of this interview, Michael A. Bernstein, MD, highlights the need for prolonged antibiotics and strong public health measures to combat tuberculosis (TB) at both the individual and population ...